RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Join our insider list and unlock access to members-only perks! Get the scoop on upcoming deals, tailored content, and unique promotions before anyone else. As part of our inner circle, you'll be the first to hear about exclusive rewards and limited-time invitations. Don’t miss out — become a valued member today!

By subscribing, you consent to receive communications from us and trusted partners. We value your privacy and ensure your data remains safe and confidential.